Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?

被引：0
|
作者：
Eric Van Cutsem
机构：
[1] Professor of Medicine and Head of the Digestive Oncology Unit at the University Hospital Gasthuisberg,
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：72 / 73
页数：1
相关论文
共 50 条
  • [1] Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
    Van Cutsem, Eric
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 72 - 73
  • [2] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Rosati, G
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (01): : 20 - 21
  • [3] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Leonard B Saltz
    Nature Clinical Practice Oncology, 2005, 2 : 20 - 21
  • [4] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Saltz, LB
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 20 - 21
  • [5] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Gerardo Rosati
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 20 - 21
  • [6] Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis
    Shao, Yen-Chen
    Chang, Yu-Yao
    Lin, Jen-Kou
    Lin, Chun-Chi
    Wang, Huann-Sheng
    Yang, Shung-Haur
    Jiang, Jeng-Kai
    Lan, Yuan-Tzu
    Lin, Tzu-Chen
    Li, Anna Fen-Yau
    Chen, Wei-Shone
    Chang, Shih-Ching
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (10) : 1359 - 1365
  • [7] Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis
    Yen-Chen Shao
    Yu-Yao Chang
    Jen-Kou Lin
    Chun-Chi Lin
    Huann-Sheng Wang
    Shung-Haur Yang
    Jeng-Kai Jiang
    Yuan-Tzu Lan
    Tzu-Chen Lin
    Anna Fen-Yau Li
    Wei-Shone Chen
    Shih-Ching Chang
    International Journal of Colorectal Disease, 2013, 28 : 1359 - 1365
  • [8] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [9] Efficacy and Toxicity of Addition of Bevacizumab to Chemotherapy in Patients with Metastatic Colorectal Cancer
    Ruan, Wen-Cong
    Che, Yue-Ping
    Ding, Li
    Li, Hai-Feng
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (10) : 718 - 724
  • [10] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Grothey, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 22 - 23
12345